Bart Penninger

SVP R&D

Bart Penninger has served as Biocartis' Senior Vice President of Research & Development (R&D) since 1 July 2025. In this role, he leads the R&D organization, overseeing assay development and the lifecycle management of on-market products. Mr. Penninger joined Biocartis in 2019, progressively advancing through roles focused on new product development and service delivery for pharma. Prior to joining Biocartis, he was an active naval officer in the Belgian Navy and held various positions in the aerospace, defense and medical device engineering industry, working at the intersection of R&D, innovation and service delivery. Mr. Penninger graduated from the Dutch Royal Naval College, holds an MSc in Navigation Technology from Nottingham University and earned an MBA from Vlerick Business School.

Roger Moody

Chief Executive Officer

More than 30 years of experience in the life science and medical technology market, experienced in scaling up public and private companies.

Randy Polonsky

Chief Financial Officer

Seasoned executive with 15+ years of experience in financial planning and analysis, corporate development, operational excellence, and leadership across both public and private equity global companies.

Bria Mertens

General Counsel

Seasoned healthcare and life sciences attorney with almost 20 years of experience across diagnostics, biotech, and precision medicine.

W. Michael Korn, MD

Chief Medical and Scientific Officer

Renowned Molecular and Gastrointestinal Oncologist with extensive experience in the development and implementation of precision oncology strategies.

Sarah Baudenelle

Chief Manufacturing Officer

Senior operations leader with 15+ years of dedicated experience in operations management. Excels in optimizing processes, streamlining efficiencies, and ensuring seamless operations in diagnostics and pharma.

Susy Spruyt

Chief People Officer

Accomplished leader with 20+ years of experience in human resources and organizational development. Keen ability to foster a culture of growth, innovation, talent management and employee well-being.

David Dejans

Chief Commercial Officer

Accomplished leader with almost 20 years of experience in managing commercial organizations in the field of molecular biology and immuno-assays.

Anthony Green

EVP Corporate & Business Development

Seasoned corporate and business development leader with 20+ years of experience advancing oncology diagnostics and molecular testing through strategic partnerships and global commercial execution.

Ben Svarczkopf

SVP Global Marketing

Accomplished leader with 25+ years of experience in clinical lab science, offering a unique blend of business acumen, clinical knowledge, and extensive biotechnology expertise.

Bart Penninger

SVP R&D

Experienced R&D leader with 20 years of experience, combining a background in engineering, innovation, and operational excellence.

Mike Kreitzinger

SVP Global Business Development

Accomplished leader with 25+ years of experience in clinical diagnostics, bringing a unique blend of business strategy, clinical diagnostic sales, and commercial leadership expertise.

Jeremiah Gerdin

VP US Commercial

Transformational commercial executive with 15 years of experience in molecular and oncology diagnostics, known for driving strategic growth, building high-performing teams, and executing market expansion.